Dianthus Therapeutics (DNTH) Short-term Investments (2017 - 2025)

Dianthus Therapeutics' Short-term Investments history runs 9 years deep, the most recent figure standing at $353.2 million for Q4 2025.

• In Q4 2025, Short-term Investments rose 39.91% year-over-year to $353.2 million; the TTM figure through Dec 2025 stood at $353.2 million (up 39.91% YoY), while the FY2025 annual figure was $353.2 million, up 39.91% from the prior year.
• Short-term Investments was $353.2 million for Q4 2025 at Dianthus Therapeutics, up from $346.6 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $353.2 million in Q4 2025 to a low of $1.8 million in Q1 2023.
• Historically, Short-term Investments has averaged $119.8 million across 5 years, with a median of $64.7 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Short-term Investments tumbled 97.9% in 2023, then soared 2557.98% in 2024.
• A 5-year view of Short-term Investments shows it stood at $45.3 million in 2021, then surged by 32.8% to $60.1 million in 2022, then plunged by 31.16% to $41.4 million in 2023, then jumped by 509.88% to $252.4 million in 2024, then jumped by 39.91% to $353.2 million in 2025.
• The last three Short-term Investments figures came in at $353.2 million (Q4 2025), $346.6 million (Q3 2025), and $244.2 million (Q2 2025), per Business Quant data.